Musashino Red Cross Hospital
In research, Musashino Red Cross Hospital stands highest in Medicine (#6,022 of 10,443 worldwide) and Health Sciences (#7,803 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 7.5× its share of world research.
- World rank, 2022–2025
- #20,187 of 28,054 · #24,704 all time
- Rank in Japan
- #582 of 1,070
- Research works
- 861 ▲ 26% vs 2013–17
- Citations
- 12k 13.4 per fractional work
- Top-10% rate
- 14.4% record average 16.5%
- Open access
- 51% world 28%
What is Musashino Red Cross Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,022 of 10,443 | 14.7% | 125 | #7615 | |
| Health SciencesDomain | #7,803 of 11,982 | 14.7% | 128 | #10148 |
Each strip is that field’s whole ranked pool, with the notch where Musashino Red Cross Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Musashino Red Cross Hospital specialise in?
Where its research is concentrated relative to its size: Surgery takes 7.5× the share of its output that it takes of world research.
- SurgerySubfield · 25.7 works7.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.5×. Every wedge is a field page.
- Medicine 4.5×
- Nursing 1.8×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Immunology and Microbiology 1.2×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Health Professions 0.5×
- Neuroscience 0.3×
- Mathematics 0.3×
- Psychology 0.2×
- Dentistry 0.1×
- Economics, Econometrics and Finance 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Environmental Science 0.1×
- Chemistry 0.0×
- Agricultural and Biological Sciences 0.0×
- Materials Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Musashino Red Cross Hospital?
Ranked on the composite score, Namiki Izumi, Yasuhiro Asahina and Jun Itakura lead among researchers whose main affiliation is Musashino Red Cross Hospital.
- 1 Namiki Izumi Japan · #34,182 worldwide 412 citations · 78 works
- 2 Yasuhiro Asahina Japan · #303,196 worldwide 57 citations · 37 works
- 3 Jun Itakura Japan · #355,471 worldwide 57 citations · 33 works
- 4 Kaoru Tsuchiya Japan · #355,573 worldwide 96 citations · 43 works
- 5 Toshihiko Nakamura Japan · #459,751 worldwide 39 citations · 35 works
- 6 Tetsuo Yamaguchi Japan · #672,265 worldwide 85 citations · 70 works
- 7 Osamu Noguchi Japan · #854,085 worldwide 32 citations · 24 works
- 8 Satoshi Umezawa Japan · #955,026 worldwide 15 citations · 16 works
- 9 Nobuhiro Hara Japan · #983,251 worldwide 17 citations · 27 works
- 10 U. Ito Japan · #984,364 worldwide 15 citations · 17 works
Which keywords describe research at Musashino Red Cross Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Hepatocellular Carcinoma, Treatment, Diagnosis, Management, Clinical Practice Guidelines, Metabolic Syndrome and Insulin Resistance.
- Therapeutic Strategies
- Magnetic Resonance Imaging
- Hepatitis C Virus
- Genetic Mutations
- Liver Cirrhosis
- SARS-CoV-2
- Coagulopathy
- Coronary Stents
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Immune Response
- NASH
- Hepatic Steatosis
- Liver Cancer
- Radiofrequency Ablation
- Insulin Resistance
- Clinical Practice Guidelines
- Diagnosis
- Hepatocellular Carcinoma
- Epidemiology
- Treatment
- Management
- Metabolic Syndrome
- Inflammation
- Survival
- Sorafenib
- NAFLD
- Surgical Management
- Atherosclerosis
- Percutaneous Coronary Intervention
- Liver Disease
- Antiviral Therapy
- Myocardial Revascularization
- Myocardial Infarction
- Hepatic Encephalopathy
- Tumor Microenvironment
- Genetic Variation
- Ribavirin
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology22▲ 3.9×50 topics
- Hepatocellular Carcinoma16▲ 52×3 topics
- Treatment15▲ 8.6×17 topics
- Diagnosis12▲ 9.2×14 topics
- Management10▲ 9.2×13 topics
- Clinical Practice Guidelines10▲ 13×10 topics
- Metabolic Syndrome9▲ 8.0×12 topics
- Insulin Resistance9▲ 13×5 topics
- Inflammation8▲ 2.8×37 topics
- Radiofrequency Ablation8▲ 50×2 topics
- Survival8▲ 39×3 topics
- Liver Cancer7▲ 91×1 topic
- Sorafenib7▲ 91×1 topic
- Hepatic Steatosis7▲ 32×2 topics
- NAFLD7▲ 41×1 topic
- NASH7▲ 41×1 topic
- Surgical Management7▲ 11×15 topics
- Immune Response6▲ 7.9×9 topics
- Atherosclerosis6▲ 15×6 topics
- Prognostic Factors6▲ 9.1×10 topics
- Percutaneous Coronary Intervention6▲ 28×4 topics
- Chemotherapy5▲ 5.3×15 topics
- Liver Disease5▲ 40×3 topics
- Immunotherapy5▲ 5.1×13 topics
- Antiviral Therapy5▲ 33×3 topics
- Coronary Stents4▲ 70×1 topic
- Myocardial Revascularization4▲ 70×1 topic
- Coagulopathy4▲ 37×2 topics
- Myocardial Infarction4▲ 12×3 topics
- SARS-CoV-24▲ 8.8×5 topics
- Hepatic Encephalopathy4▲ 52×1 topic
- Liver Cirrhosis4▲ 52×1 topic
- Tumor Microenvironment4▲ 6.4×7 topics
- Genetic Mutations4▲ 5.8×11 topics
- Genetic Variation3▲ 11×5 topics
- Hepatitis C Virus3▲ 67×1 topic
- Ribavirin3▲ 67×1 topic
- Magnetic Resonance Imaging3▲ 8.4×3 topics
- Neoadjuvant Therapy3▲ 8.2×4 topics
- Therapeutic Strategies3▲ 20×2 topics
Which research topics does Musashino Red Cross Hospital publish most on?
By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Coronary Interventions and Diagnostics and Liver Disease and Transplantation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 7 works
- 2 Liver Disease Diagnosis and Treatment Epidemiology 7 works
- 3 Coronary Interventions and Diagnostics Surgery 4 works
- 4 Liver Disease and Transplantation Hepatology 4 works
- 5 Hepatitis C virus research Hepatology 3 works
- 6 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 3 works
- 7 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 2 works
- 8 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 9 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 2 works
- 10 Respiratory viral infections research Epidemiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Musashino Red Cross Hospital's research output changed?
Output in 2018–2022 was 26% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.